Stoke Therapeutics (STOK)
NASDAQ:STOK
Want to see STOK full AI Analyst Report?
Stoke Therapeutics (STOK) Ownership Overview
34.67% Insiders
15.88% Mutual Funds
16.22% Other Institutional Investors
13.67% ETFs
19.57% Public Companies and
Individual Investors
The ownership structure of Stoke Therapeutics (STOK) stock is a mix of institutional, retail, and individual investors. Approximately 45.76% of the company’s stock is owned by Institutional Investors, 34.67% is owned by Insiders, and 19.57% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 19, 2026 | xxxxxxxxxxxxx | $119289 | |
Mar 19, 2026 | xxxxxxxxxxxxx | $285849 | |
Mar 19, 2026 | xxxxxxxxxxxxx | $147118 | |
Aug 20, 2025 | xxxxxxxxxxxxx | $51135 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $2735040 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $3667135 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $995652 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,161,713 | Insider | 27.56% | 503,524,659 | |
| 3,906,181 | Insider | 6.27% | 114,607,351 | |
| 3,336,697 | Institution | 5.36% | 97,898,690 | |
| 2,786,057 | Institution | 4.47% | 81,742,912 | |
| 2,334,577 | Institution | 3.75% | 68,496,489 | |
| 2,196,148 | Institution | 3.53% | 64,434,982 | |
| 1,823,500 | Institution | 2.93% | 53,501,490 | |
| 1,542,594 | Institution | 2.48% | 45,259,708 | |
| 1,333,535 | Institution | 2.14% | 39,125,917 | |
| 1,198,602 | Institution | 1.92% | 35,166,983 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,196,148 | Institution | 3.53% | 64,434,982 | |
| 1,542,594 | Institution | 2.48% | 45,259,708 | |
| 1,198,602 | Institution | 1.92% | 35,166,983 | |
| 702,700 | Institution | 1.13% | 20,617,218 | |
| 677,952 | Institution | 1.09% | 19,891,112 | |
| 532,900 | Institution | 0.86% | 15,635,286 | |
| 482,590 | Institution | 0.77% | 14,159,191 | |
| 473,543 | Institution | 0.76% | 13,893,752 | |
| 371,153 | Institution | 0.60% | 10,889,629 | |
| 267,124 | Institution | 0.43% | 7,837,418 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,723,382 | Institution | 2.77% | 56,113,318 | |
| 1,231,576 | Institution | 1.98% | 40,198,641 | |
| 1,143,659 | Institution | 1.84% | 37,157,481 | |
| 574,533 | Institution | 0.92% | 18,706,794 | |
| 403,366 | Institution | 0.65% | 13,105,361 | |
| 328,743 | Institution | 0.53% | 10,680,860 | |
| 251,410 | Institution | 0.40% | 8,206,022 | |
| 241,155 | Institution | 0.39% | 7,852,007 | |
| 181,893 | Institution | 0.29% | 5,909,704 | |
| 179,741 | Institution | 0.29% | 5,866,746 |
FAQ
Who Owns Stoke Therapeutics (STOK)?
According to the latest TipRanks data, approximately 16.22% of the company's stock is held by institutional investors, 34.67% is held by insiders, and 19.57% is held by retail investors.
What percentage of Stoke Therapeutics (STOK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 16.22% of Stoke Therapeutics (STOK) stock is held by institutional investors.
What percentage of Stoke Therapeutics (STOK) stock is held by retail investors?
According to the latest TipRanks data, approximately 19.57% of Stoke Therapeutics (STOK) stock is held by retail investors.
Who owns the most shares of Stoke Therapeutics (STOK)?
Seth Loring Harrison owns the most shares of Stoke Therapeutics (STOK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.